Sei Investments CO Argenx Se Transaction History
Sei Investments CO
- $74.7 Billion
- Q3 2024
A detailed history of Sei Investments CO transactions in Argenx Se stock. As of the latest transaction made, Sei Investments CO holds 380,695 shares of ARGX stock, worth $215 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
380,695
Previous 381,544
0.22%
Holding current value
$215 Million
Previous $164 Million
25.83%
% of portfolio
0.28%
Previous 0.24%
Shares
25 transactions
Others Institutions Holding ARGX
# of Institutions
400Shares Held
30.9MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.28 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$1.98 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.4 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$959 Million0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$699 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $31.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...